<?xml version="1.0" encoding="UTF-8"?>
<p id="p0085">In addition to current antiviral drugs recommended by the latest Chinese guidance,
 <xref rid="bib7" ref-type="bibr">
  <sup>7</sup>
 </xref> tocilizumab is recommended for severe patients with extensive lung disease and elevated IL-6 levels. For severe patients with rapid disease progression and excessive activation of inflammatory response, short-term corticosteroids could be considered to use at early stage. Some therapeutic drugs may cause serious adverse reactions, including hemolytic anemia, cardiotoxicity, infection, femoral head necrosis, and teratogenic effects. Therefore, pharmacists should cooperate with clinicians to formulate medication regimens to avoid inappropriate high-dose medications or multi-drug combinations. Besides, pharmacists should closely monitor the safety of drugs, identify adverse drug events early and adjust the medication regimens timely when attending pharmaceutical ward round and consultations.
</p>
